The Efficacy and Safety of Tislelizumab Combined With Anlotinib and S1 Plus Oxaliplatin as Neoadjuvant Therapy for the Locally Advanced Adenocarcinoma of Esophagogastric Junction

Name: The Efficacy and Safety of Tislelizumab Combined With Anlotinib and S1 Plus Oxaliplatin as Neoadjuvant Therapy for the Locally Advanced Adenocarcinoma of Esophagogastric Junction
License: Public Domain

Fujian Cancer Hospital

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

immunotherapy gastroesophageal junction

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 272356
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.